Abstract: The present disclosure describes various aspects of various devices, and methods of making and using the devices, for measuring bioimpedance of tissues within a patient's body, such as GI tract tissue. The devices entail using various implementations of capsules or other housings that allow for ingestion or other insertion into a body of the device, equipped with microfabricated sensors and embedded circuitry enabling wireless communication. Among other benefits, this approach addresses a gap in conventional GI tract monitoring devices and methods to non-invasively access the small intestine and directly measure the inflammatory state of intestinal tissue, including ischemia, edema, and mucosal abnormalities.